-
Panel explores challenges and strategies to overcome therapeutic inertia in type 2 diabetes
Therapeutic inertia is a common problem in managing type 2 diabetes. Experts including Kevin M. Pantalone, DO, ECNU, FACE, addressed how it can be prevented, such as achieving A1C targets within a year of treatment, leveraging the entire health care team in the patient’s journey, and having accessibility to the patient’s electronic health record.
-
Innovation Challenge aims to connect novel ideas for diabetes care with investors
New to the Scientific Sessions lineup, the Innovation Challenge invites six contestants to pitch their concepts for improving the lives of people living with diabetes before a panel of potential funders. Three finalists will earn a private audience with the judges, explained ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD.
-
Session to examine the emerging potential of immunotherapy in type 1 diabetes prevention
A panel including Ellen Leschek, MD, will discuss teplizumab clinical trial results and the role of the CD3-directed monoclonal antibody in delaying the progression from stage 2 type 1 diabetes to stage 3. Joining Dr. Lesheck will be researchers, clinicians, and a patient with type 1 diabetes.
-
Pediatric experts will debate whether technology or immunomodulation is better for type 1 diabetes management
Michael J. Haller, MD, and Antionette Moran, MD, will present data and arguments in support of technology and immunomodulation, respectively, in treating patients with type 1 diabetes. Dr. Haller said most experts likely agree there will be a role for both going forward and each should be discussed and offered to patients.
-
Genetic studies, risk prediction models have growing roles in diabetes research and management
Genome-wide association studies and polygenic risk scores are important tools in the field of genetics and have shown to also impact diabetes research. Experts including Inês Barroso, PhD, will present information on how GWAS and PRS have helped in the prevention, early diagnosis, and management of type 2 diabetes.
-
ADA recognizes top 10 health disparities-related abstracts of the Scientific Sessions
The Health Disparities Committee of the American Diabetes Association® has chosen the top 10 abstracts for presentation. These abstracts focus on health care disparities in diabetes outcomes, showcase research that explores the underlying factors in diabetes disparities, and demonstrate practical interventions that may contribute to eliminating those disparities.